It has been confirmed through an official announcement that Allergan is set to acquire KYTHERA Biopharmaceuticals Inc in a cash and equity transaction valued at $75 per KYTHERA share – around $2.1 billion.
KYTHERA is a biopharmaceutical company focused on developing prescription products and is best known for its lead product KYBELLA™, which has been approved as a non-surgical treatment for contouring moderate to severe submental fullness, commonly referred to as double chin.
Brent Saunders, CEO and President of Allergan, said:
“The acquisition of KYTHERA is a strategic investment that strengthens our leading global position in aesthetics and continues to position us for long-term growth”
“KYBELLA™ is an exciting new product that offers patients the first and only clinically-proven, non-surgical treatment for submental fullness (excess fat under the chin). As a leader in aesthetics, we know our customers are looking to offer their patients new options beyond traditional facial aesthetics. KYBELLA™ will do that while complementing our market leading facial aesthetics portfolio, which includes BOTOX®, JUVEDERM® XC, JUVEDERM VOLUMA® XC, LATISSE® and SKINMEDICA.”
Keith Leonard, CEO and President of KYTHERA responded, saying:
“Allergan’s world-class medical aesthetics, global footprint, history and commitment to developing leading aesthetic products makes them ideally suited to realize the maximum commercial potential of KYBELLA™”
Double Chin Treatment
Submental fullness is a common condition, which has been estimated by the American Society for Dermatologic Surgery to affect 67% of consumers.
The development of a double chin can lend the face an older and heavier look.
Reducing the fat beneath the chin, tackling double chin and contouring the area beneath the jawline.
KYBELLA™ is not yet available in the UK, but is expected later in 2015.
SkinViva Training and Allergan
SkinViva Training work closely with Allergan in the UK and are one of 30 companies to be part of Allergan’s elite training academy, as well as working together with Allergan representatives to build the consumer business SkinViva.
We will therefore bring you further news of this exciting product as it becomes available.
Cosmetic Treatments Training
Botox and Fillers Courses, Manchester
SkinViva Training Academy offers a comprehensive range of botox and fillers training courses designed for medical professionals such as suitably qualified and registered medical professionals who wish to learn and build on their skills in delivering these procedures.
SkinViva Training was established by Dr Tim Pearce MBChB BSc (Hons) MRCGP. The SkinViva Training team upholds high standards of clinical training providing a combination of fully-supervised practical experience together with essential theory.
For further information, to discuss which course is right for you, to enquire about availability or to book a training course please call 0161 850 2491, or email firstname.lastname@example.org.
What others say about this post? (12 Comments)
Hi I like more info about the training for kybella Botox and dermafillers
Hi Yahaira, thanks for your enquiry, we are really excited about this treatment and as soon as we have an update from the manufacturer we will share info via our website. It is anticipated this will be end of this year, early next. Regards Georgie
Hi I would like to book some training for KYBELLA injections pls. I would like to book training asap pls
Hi Shazia, we don’t offer training for Kybella at this point in time – the product has not yet been approved for the UK market, pending clearance by MHRA.
We do have a variety of other training courses which you may consider – please see courses and dates/availability for more information on what’s available. You may also be interested in FAQs including course entry criteria.
If you’d like to discuss further, we welcome enquiries over the phone on 0161 850 2491 or by email email@example.com. Office hours are Monday-Saturday 9.30-17.30.
is this available in Scotland yet.
Belkara (UK name for Kybella) is awaiting approval/licences via the MHRA (Department of Health agency whose role is to assess and authorise medicines and medical devices in the UK). We expect this to be available in 2017.
Hi. Do you now offer kybella courses?
Sorry, we don’t offer training for Kybella yet the product has not yet been approved for the UK market. It is still pending clearance by MHRA and this is out of our hands.
We do have a variety of other training courses which you may consider – please see courses and dates/availability at https://www.skinvivatraining.com/training-courses/upcoming/ for more information on what’s available. You may also be interested in FAQs including course entry criteria.
If you’d like to discuss further, we welcome enquiries over the phone on 0161 850 2491 or by email firstname.lastname@example.org.
Any news when we can get kybella in WAles? 🙂
I would be interested in having the kybella injections. Could you please inform me when you have it available.
Hi, Kybella has FDA approval in the USA, but is not ready yet for distribution and use in the UK market.
For details of our current skin treatments see http://www.skinviva.com.